Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ovid Therapeutics Inc.

0.3368
+0.01183.63%
Post-market: 0.3325-0.0043-1.28%19:58 EDT
Volume:768.73K
Turnover:259.13K
Market Cap:23.94M
PE:-0.90
High:0.3596
Open:0.3483
Low:0.3204
Close:0.3250
Loading ...
Mar 08, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Correspondence

Form CORRESP - Correspondence
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 18, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 04, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 05, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 05, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2023

Major Issues Report

8-K - Current report
May 01, 2023

Major Issues Report

8-K - Current report
Apr 27, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]